Minimally Conscious State Clinical Trial
Official title:
Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness: a Double-blind Placebo-controlled Clinical Study.
The purpose of this study is to characterize and improve pain and nociception management in patients with disorders of consciousness (DOC). This project is divided into two phases, a first phase to evaluate pain level and a second phase which consist of a clinical trial to evalute pain medication efficacy. The main aim is to evaluate the use of the Nociception Coma Scale-Revised (NCS-R) and its cut-off score (i.e., 5) as an assessment and management tool to define guidelines for managing pain in patients with DOC. In this double-blind, placebo-controlled clinical study, we will evaluate the use of analgesic treatments in reducing pain in subacute/chronic patients. The project will also allow us to validate the NCS-R cut-off score defined previously.
The study will be performed within one week (i.e, 7 days) and consists of two phases: - Phase 1 "Patients selection (D0)": Patients will be assessed by the NCS-R during experimental stimulation (rest, tactile, noxious) and mobilizations (physiotherapy). Patients with potential pain will be included in the phase 2. - Phase 2 "Analgesic administration (D1 and D2)": double-blind placebo-controlled randomized clinical trial on potential responders identified in phase 1. A medical doctor of our team will suggest to the physician in charge to prescribe the dedicated medication. One placebo and one real treatment will be administered on day 1 and 2 by the nurses at least half-hour before the physiotherapy. Randomization between day 1 and 2 will be applied at that time. For each day of phase 1 and 2, several assessments will be performed: NCS-R, CRS-R and spasticity assessment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02288533 -
Transcranial Direct Current Stimulation Effects in Patients With Chronic Consciousness Disorders
|
N/A | |
Completed |
NCT03494218 -
Reliability and Validity of the NCS (NCS-R)-Chinese Version
|
N/A | |
Recruiting |
NCT02591069 -
Vagal Nerve Stimulation in Coma Patients
|
N/A | |
Active, not recruiting |
NCT03826407 -
Development of a Point of Care System for Automated Coma Prognosis
|
||
Completed |
NCT04687553 -
Validation of the Chinese Version of the SECONDs
|
N/A | |
Completed |
NCT05536921 -
Eye Tracking Technology in the Diagnosis of Neurological Patients
|
||
Completed |
NCT03126929 -
Further Psychometric Data for the Reliability and the Diagnostic Validity of CRS-R
|
N/A | |
Completed |
NCT03732092 -
The Effects of Olfactory Stimulation on Diagnosis and Prognosis of DOC Patients
|
||
Completed |
NCT03508336 -
The Initiation of Swallowing Can Indicate the Prognosis of DOC
|
||
Completed |
NCT04921683 -
The Use of LIFUP in Chronic Disorders of Consciousness
|
N/A | |
Terminated |
NCT03367078 -
tDCS in Patients With Disorder of Consciousness Due to Severe Acquired Brain Injury
|
||
Recruiting |
NCT04798456 -
Aiming for a Better Understanding and Improvement of the Diagnosis and Prognosis of Patients With Disorders of Consciousness Through Multimodal Observations
|
||
Not yet recruiting |
NCT04248946 -
Neural, Behavioural, and Clinical Effects of tDCS in PDOC; Feasibility Study
|
N/A | |
Completed |
NCT01820923 -
Transcranial Brain Stimulation in Vegetative State Patients
|
N/A | |
Recruiting |
NCT01027572 -
Thalamic Stimulation of Patients in Vegetative or Minimally Conscious State
|
Phase 2 | |
Completed |
NCT00557076 -
The Efficacy of Familiar Voice Stimulation During Coma Recovery
|
N/A | |
Recruiting |
NCT03910959 -
Therapeutic Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State
|
N/A | |
Recruiting |
NCT04010838 -
Spinal Cord Stimulation in Patients With Disorders of Consciousness
|
N/A | |
Completed |
NCT04139239 -
Diagnostic Accuracy of the Vegetative and Minimally Conscious State
|
||
Recruiting |
NCT03007784 -
Two Intensities of Transcranial Direct Current Stimulation to Improve Consciousness in Severely Brain Injured Patients
|
Phase 3 |